Skip to main content

Biolife Solutions Inc

BLFS
Exchange
Nasdaq
Industry
Electromedical & Electrotherapeutic Apparatus
SEC CIK
0000834365

No open-market purchases or sales by Biolife Solutions Inc insiders were filed in the last 90 days; 216 institutions reported holding it in 13F filings for Q2 2026, worth $1.40B in total; no superinvestor holds it.

Q4 2024 vs. Q3 2024

How the institutions holding Biolife Solutions Inc changed between Q3 2024 and Q4 2024.

All holders in Q4 2024All holders in Q3 2024

13F holders of BLFS: Q3 2024 compared with Q4 2024
MeasureQ3 2024Of which not filed for Q4 2024Q4 2024Change
Holders1952181−12
Shares45.3M492.9K46.8M+2.04M (+4.6%)
Value$1.13B$12.7M$1.21B+$94.1M (+8.4%)

2 institutions that held it in Q3 2024 haven't filed for Q4 2024 yet. Not filing isn't selling, so the changes leave them out.

New holders (23)

Institutions that held Biolife Solutions Inc at the end of Q4 2024 but not at the end of Q3 2024.

Sold out (35)

Institutions that held Biolife Solutions Inc at the end of Q3 2024 and filed for Q4 2024 without it.

Not filed for Q4 2024 yet (2)

Institutions that held Biolife Solutions Inc at the end of Q3 2024 and haven't filed a 13F for Q4 2024. Not filing isn't selling, so they aren't counted as sold out.

Institutions holding BLFS in Q3 2024 that haven't filed for Q4 2024
InstitutionShares, Q3 2024Value, Q3 2024
Eagle Asset Management Inc352,897$9.22M
Raymond James & Associates139,997$3.51M